Defining parameters for successful immunocytotherapy of persistent viral infection

Virology

Volumn 266, Issue 2, 2000, Pages 257-263

  Berger, Dietmar P ^a   Homann, Dirk ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; INFECTION CONTROL; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 0034688296     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0074     Document Type: Article

References (32)

1. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B., Shaw G. M. Antiviral pressure exerted by human immunodeficiency virus type 1-specific cytotoxic T lymphocyte (CTL) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:1997;205-211.
2. Byrne J. A., Oldstone M. B. A. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. J. Immunol. 136:1986;698-704.
3. Cardin R. D., Brooks J. W., Sarawar S. R., Doherty P. C. Progressive loss of CD8(+) T cell-mediated control of gamma-herpesvirus in the absence of CD4(+) T cells. J. Exp. Med. 184:1996;863-871.
4. Dawson N. J. The surface-area-body-weight relationship in mice. Aust. J. Biol. Sci. 20:1967;687-690.
5. Dutko F. J., Oldstone M. B. A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1983;1689-1698.
6. Guidotti L. G., Ishikawa T., Hobbs M. V., Matzke B., Schreiber R., Chisari F. V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
7. Hasenkrug K. J., Brooks D. M., Dittmer U. Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:1998;6559-6564.
8. Homann D., Tishon A., Berger D. P., Weigle W. O., von Herrath M. G., Oldstone M. B. A. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72:1998;9208-9216.
9. Kalams S. A., Walker B. D. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:1998;2199-2204.
10. + cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J. Immunol. 146:1991;1955-1963.
11. Klein M. R., van Baalen C. A., Holwerda A. M., Kerkhof Garde S. R., Bende R. J., Keet I. P., Eeftinck-Schattenkerk J. K., Osterhaus A. D., Schuitemaker H., Miedema F. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection. A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1995;1365-1372.
12. Kundig T. M., Schorle H., Bachmann M. F., Hengartner H., Zinkernagel R. M., Horak I. Immune responses in interleukin-2-deficient mice. Science. 262:1993;1059-1061.
13. Lewicki H., Tishon A., Borrow P., Evans C. F., Gairin J. E., Hahn K. M., Jewell D. A., Wilson I. A., Oldstone M. B. CTL escape viral variants. I. Generation and molecular characterization. Virology. 210:1995;29-40.
14. Li C. R., Greenberg P. D., Gilbert M. J., Goodrich J. M., Ridell S. R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood. 83:1994;1971-1979.
15. Lucas K., Small T., Heller G., Dupont B., O'Reilly R. J. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 87:1996;2594-2603.
16. + cytotoxic T cell responses during chronic viral infection. J. Virol. 68:1994;8056-8063.
17. Moskophidis D., Lechner F., Pircher H., Zinkernagel R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:1993;758-761.
18. Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J., Zajac A. J., Miller J. D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
19. Oldstone M. B. Immunotherapy for virus infection. Curr. Top. Microbiol. Immunol. 134:1987;211-229.
20. Oldstone M. B. A., Blount P., Southern P. J., Lampert P. W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
21. Planz O., Ehl S., Furrer E., Horvath E., Brundler M. A., Hengartner H., Zinkernagel R. M. A critical role for neutralizing antibody-producing B cells, CD4(+) T cells, and interferon in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA. 94:1997;6874-6879.
22. Riddell S. R., Elliott M., Lewinsohn D. A., Gilbert M. J., Wilson L., Manley S. A., Lupton S. D., Overell R. W., Reynolds T. C., Corey L., Greenberg P. D. T cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:1996;216-223.
23. Rooney C. M., Smith C. A., Ng C. Y., Loftin S. K., Sixbey J. W., Gan Y., Srivastava D. K., Bowman L. C., Krance R. A., Brenner M. K., Heslop H. E. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 92:1998;1549-1555.
24. + T cell responses associated with control of viremia. Science. 278:1997;1447-1450.
25. + T cell interactions in IFN-gamma and IL-4 responses to viral infections: Requirements for IL-2. J. Immunol. 160:1998;5007-5017.
26. Tishon A., Lewicki H., Rall G., von Herrath M., Oldstone M. B. A. An essential role for type 1 interferon gamma in terminating persistent viral infection. Virology. 212:1995;244-250.
27. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T cell clones from the donor. N. Engl. J. Med. 333:1995;1038-1044.
28. Whitmire J. K., Asano M. S., Murali-Krishna K., Suresh M., Ahmed R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:1998;8281-8288.
29. Wright K. E., Ahmed R., Buchmeier M. J. Persistent infection of mice with Pichinde virus associated with failure to thrive. Microb. Pathog. 19:1995;73-82.
30. Yee C., Riddell S. R., Greenberg P. D. Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9:1997;702-708.
31. Zajac A. J., Blattman J. N., Murali-Krishna K., Sourdive D. J. D., Suresh M., Altman J. D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:1998;2205-2213.
32. Zinkernagel R. M., Doherty P. C. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:1979;51-177.